WAT Waters Corporation

Waters Improves Ease and Reliability of Small Molecule Analysis with ACQUITY RDa Detector

Waters Corporation (NYSE:WAT) today released the featuring SmartMS™, the company’s newest time-of-flight (TOF) mass spectrometer (MS) for small molecule analysis for pharmaceutical, academic, food, and forensics applications. The accurate-mass ACQUITY™ RDa Detector can be quickly deployed and operated to enable faster and more informed decision-making across a broad set of applications.

This press release features multimedia. View the full release here:

The ACQUITY RDa Detector featuring SmartMS technology is a time-of-flight mass detector for making accurate-mass measurements of small molecules during pharmaceutical impurity analyses, forced degradation studies, food and natural products analyses and seized drug profiling. (Photo: Business Wire)

The ACQUITY RDa Detector featuring SmartMS technology is a time-of-flight mass detector for making accurate-mass measurements of small molecules during pharmaceutical impurity analyses, forced degradation studies, food and natural products analyses and seized drug profiling. (Photo: Business Wire)

“With the ACQUITY RDa Detector, we've taken the complexity of operating a mass spectrometer and put it behind the user interface so that the bench scientist doesn't have to worry about how it works, but about what to do with the high-quality, reproducible results the detector produces,” said Ian King, Senior Vice President - Global Products, Waters Corporation. “The ACQUITY RDa Detector’s high mass accuracy, automated setup and streamlined workflows offer laboratories a purpose-built high-performance mass spectrometer to support increasingly complex small molecule analysis projects with ease.”

Simplified Set Up and Operation for Confidence and Faster Decision-Making

From setup to results, the ACQUITY RDa Detector is designed for ease-of-use with intuitive system health checks and dedicated results-oriented workflows. With SmartMS, users can identify analytes more accurately and confidently evaluate outcomes with end-to-end robust, reliable workflows for routine applications. Paired with a simple one-button start, the RDa Detector reduces the extent of training, limits downtime, and ensures consistent, reproducible results.

“In the pharma industry, the Waters RDa Detector meets regulatory and production challenges for which a satisfactory solution doesn’t exist,” said Marc Foulon, Director, Pharmaphysic, an analytical development laboratory providing analytical services for the cosmetic, chemical and pharmaceuticals industries.

Big Impact on Small Molecule Analysis

The ACQUITY RDa Detector is optimized for small molecule applications where quality, compliance and data integrity are critical. These include impurity analysis, forced degradation studies, lipid screening, natural products profiling, food contaminant analysis, seized and controlled drug profiling, and general accurate-mass measurements.

For improved usability and faster outcomes, the ACQUITY RDa Detector operates on , an open software platform designed to enhance the value that the RDa brings to laboratories with new functionality, features and software updates. Providing a complete audit trail for acquisition, processing and reporting of data, waters_connect enables seamless compliance and the highest standards of data integrity. With the option of system qualification, the platform is suitable for regulated and non-regulated laboratories alike.

Featuring an array of robust functionalities, simple operation, and a compact form factor, the ACQUITY RDa Detector simplifies the process of making high performance accurate- mass measurements.

The ACQUITY RDa Detector is now available worldwide from Waters and its authorized distributors.

Additional Resources

  • Read our brochure:
  • Read our application note
  • Read our application note
  • Read our application note
  • Learn more about the on our web site.
  • Connect with Waters via , , and

About Waters Corporation ()

(NYSE:WAT), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,000 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.

ACQUITY, RDa, SmartMS and waters_connect are trademarks of Waters Corporation.

EN
10/03/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Waters Corporation

Waters Corp: 1 director

A director at Waters Corp bought 1,000 shares at 332.900USD and the significance rating of the trade was 87/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

 PRESS RELEASE

Waters Launches its Most Sensitive and Compact Clinical IVD System wit...

MONTEREY, Calif.--(BUSINESS WIRE)-- MSACL Conference 2023--Waters Corporation (NYSE:WAT) today unveiled its next generation Xevo TQ Absolute IVD mass spectrometer, expanding its family of for clinical diagnostic applications. This press release features multimedia. View the full release here: Waters' newest MassTrak IVD LC-MS/MS System featuring the Xevo TQ Absolute IVD tandem quadrupole mass spectrometer (in dark grey), is up to five times more sensitive than similar commercial mass spectrometers for quantifying analytes in samples of saliva, breath, and dried blood spots. (Photo: Business...

 PRESS RELEASE

Waters Corporation Appoints Richard Fearon to Board of Directors

MILFORD, Mass.--(BUSINESS WIRE)-- Waters™ Corporation (NYSE:WAT) today announced the appointment of Richard Fearon to its Board of Directors, effective March 27, 2023. Mr. Fearon is the former Vice Chairman and Chief Financial and Planning Officer of Eaton Corporation, a multinational power management company. “Rick’s expertise is at the intersection of financial excellence, strategic development and transformation, which are the key pillars of Waters’ growth plan. We are confident that Rick’s unique skillset will complement our Board well and we look forward to benefiting from his insights a...

 PRESS RELEASE

Waters lance le système de CLHP Alliance iS de nouvelle génération, qu...

PHILADELPHIE--(BUSINESS WIRE)-- PITTCON 2023 – Waters Corporation (NYSE:WAT) a lancé aujourd'hui , le système intelligent de CLHP de nouvelle génération, conçu pour réduire le risque de conformité en ajoutant de nouveaux niveaux de détection proactive des erreurs, de résolution des problèmes et une facilité d’utilisation. Lorsqu’il est associé au conforme et à de Waters, le système de chromatographie liquide à haute performance (CLHP) Alliance iS permet de rationaliser la tâche consistant à faire des mesures exactes et précises en détectant et éliminant les erreurs courantes jusqu’à 40 %.i C...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch